Location: Paris, France
Date: September 2 to September 5
30th European Collage of Neuropsychopharmacology Congress.
Functional impairment in patients with major depressive disorder
Addressing patients’ needs across the spectrum of mood disorders
The validation of THINC-it™ Abstract
Can D2 partial agonists improve functioning in clinical practice?
Continuous treatment in schizophrenia: addressing the controversies
Redefining Treatment Goals for Difficult to Treat Depression
Antipsychotic side effects may have a negative impact on patient functioning
From theory to practice - Applicability of the e-health tool in clinical practice: initial pharmacological treatment in recent-onset schizophrenia; Treatment-resistant schizophrenia – clinical presentation, neurobiology and treatment considerations